Prothena Corp Q4 2023 GAAP EPS $(1.26) Misses $(1.22) Estimate, Sales $316.00K Miss $2.15M Estimate
Portfolio Pulse from Benzinga Newsdesk
Prothena Corp (NASDAQ:PRTA) reported Q4 2023 GAAP EPS of $(1.26), missing the $(1.22) estimate, and sales of $316.00K, missing the $2.15M estimate. This represents a significant decrease from the previous year's earnings and sales.
February 15, 2024 | 9:10 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Prothena Corp reported a significant miss in both EPS and sales for Q4 2023, with a drastic decrease compared to the previous year.
The miss in both earnings per share and sales, especially by such large margins, is likely to negatively impact investor sentiment and could lead to a decrease in stock price in the short term. The comparison to the previous year's performance further emphasizes the company's current struggles.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100